HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-palmitoylsphingosine

structure given in first source; RN given refers to (R*,S*-(E))-isomer
Also Known As:
C(16)-ceramide; C16-0(palmitoyl)ceramide; C16-ceramide; C16-palmitoylceramide; N-palmitoylsphingosine, (R*,S*-(E))-(+-); N-palmitoylsphingosine, R-(R*,S*-(E)); NFA(C16)CER; ceramide-C16; pCer cpd; palmitoylceramide
Networked: 26 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ogretmen, Besim: 5 articles (01/2018 - 10/2007)
2. Garrett-Mayer, Elizabeth: 3 articles (01/2018 - 05/2015)
3. Lu, Ping: 3 articles (01/2018 - 05/2015)
4. Voelkel-Johnson, Christina: 3 articles (01/2018 - 05/2015)
5. Bielawska, Alicja: 3 articles (05/2015 - 06/2008)
6. Esmaeilniakooshkghazi, Amin: 2 articles (10/2018 - 01/2016)
7. Fekry, Baharan: 2 articles (10/2018 - 01/2016)
8. Krupenko, Natalia I: 2 articles (10/2018 - 01/2016)
9. Krupenko, Sergey A: 2 articles (10/2018 - 01/2016)
10. Szulc, Zdzislaw M: 2 articles (10/2018 - 09/2013)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Insulin Resistance
3. Colitis
4. Neoplasms (Cancer)
5. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. dihydroceramide desaturase
2. Enzymes
3. Sodium
4. Salts
5. Dextrans (Dextran)
6. Ceramides
7. Sphingolipids
8. N-caproylsphingosine
9. Histone Deacetylase 1
10. Therapeutic Uses

Related Therapies and Procedures

1. Therapeutics